Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oxymorphone | 4 | 2018 | 9 | 1.610 |
Why?
|
| Substance Abuse, Intravenous | 3 | 2018 | 30 | 1.150 |
Why?
|
| Analgesics, Opioid | 3 | 2018 | 251 | 1.010 |
Why?
|
| Opioid-Related Disorders | 2 | 2018 | 68 | 1.000 |
Why?
|
| Respiratory Insufficiency | 2 | 2020 | 60 | 0.730 |
Why?
|
| Antacids | 1 | 2021 | 4 | 0.670 |
Why?
|
| Calcium Carbonate | 1 | 2021 | 8 | 0.670 |
Why?
|
| Vasospasm, Intracranial | 1 | 2021 | 13 | 0.660 |
Why?
|
| Hypercalcemia | 1 | 2021 | 12 | 0.660 |
Why?
|
| Hypnotics and Sedatives | 1 | 2020 | 31 | 0.640 |
Why?
|
| Acute Lung Injury | 1 | 2020 | 36 | 0.630 |
Why?
|
| Bacteremia | 2 | 2017 | 66 | 0.590 |
Why?
|
| Thrombotic Microangiopathies | 2 | 2016 | 8 | 0.540 |
Why?
|
| Patient Admission | 1 | 2017 | 54 | 0.490 |
Why?
|
| Clostridium sordellii | 1 | 2016 | 1 | 0.490 |
Why?
|
| Liposarcoma | 1 | 2016 | 2 | 0.490 |
Why?
|
| Clostridium Infections | 1 | 2016 | 10 | 0.490 |
Why?
|
| Immunocompromised Host | 1 | 2016 | 53 | 0.480 |
Why?
|
| Intensive Care Units | 1 | 2017 | 121 | 0.470 |
Why?
|
| Kidney | 2 | 2018 | 521 | 0.450 |
Why?
|
| Plasma Exchange | 2 | 2018 | 13 | 0.450 |
Why?
|
| Brain | 1 | 2021 | 968 | 0.410 |
Why?
|
| Delayed-Action Preparations | 3 | 2018 | 33 | 0.300 |
Why?
|
| Intubation, Intratracheal | 2 | 2020 | 56 | 0.280 |
Why?
|
| Respiration, Artificial | 2 | 2020 | 98 | 0.280 |
Why?
|
| Female | 8 | 2021 | 19955 | 0.260 |
Why?
|
| Young Adult | 3 | 2020 | 2652 | 0.240 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 2 | 2018 | 12 | 0.240 |
Why?
|
| Time Factors | 2 | 2020 | 2203 | 0.210 |
Why?
|
| Humans | 9 | 2021 | 32286 | 0.210 |
Why?
|
| North Carolina | 2 | 2018 | 1300 | 0.200 |
Why?
|
| Middle Aged | 4 | 2021 | 11848 | 0.200 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 501 | 0.200 |
Why?
|
| Nimodipine | 1 | 2021 | 2 | 0.170 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2021 | 49 | 0.160 |
Why?
|
| Calcium Channel Blockers | 1 | 2021 | 53 | 0.160 |
Why?
|
| Cerebral Angiography | 1 | 2021 | 60 | 0.160 |
Why?
|
| Deep Sedation | 1 | 2020 | 3 | 0.160 |
Why?
|
| Methylprednisolone | 1 | 2020 | 14 | 0.160 |
Why?
|
| Propofol | 1 | 2020 | 20 | 0.160 |
Why?
|
| Analgesia | 1 | 2020 | 29 | 0.160 |
Why?
|
| Retrospective Studies | 2 | 2018 | 3612 | 0.150 |
Why?
|
| Disease Progression | 2 | 2018 | 591 | 0.150 |
Why?
|
| Lung | 1 | 2020 | 263 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 716 | 0.140 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 99 | 0.140 |
Why?
|
| Drug Compounding | 1 | 2018 | 36 | 0.140 |
Why?
|
| Factor IX | 1 | 2018 | 11 | 0.140 |
Why?
|
| Hemophilia B | 1 | 2018 | 6 | 0.140 |
Why?
|
| Postoperative Hemorrhage | 1 | 2018 | 38 | 0.140 |
Why?
|
| Administration, Oral | 1 | 2018 | 200 | 0.140 |
Why?
|
| Perioperative Care | 1 | 2018 | 51 | 0.130 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 264 | 0.130 |
Why?
|
| Coronary Artery Bypass | 1 | 2018 | 100 | 0.130 |
Why?
|
| Male | 5 | 2018 | 19448 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2018 | 236 | 0.130 |
Why?
|
| Hospital Mortality | 1 | 2018 | 197 | 0.130 |
Why?
|
| Cellulitis | 1 | 2017 | 12 | 0.130 |
Why?
|
| Endocarditis, Bacterial | 1 | 2017 | 15 | 0.130 |
Why?
|
| Renal Replacement Therapy | 1 | 2017 | 18 | 0.130 |
Why?
|
| Abscess | 1 | 2017 | 28 | 0.120 |
Why?
|
| Comorbidity | 1 | 2018 | 563 | 0.120 |
Why?
|
| Shock, Septic | 1 | 2016 | 26 | 0.120 |
Why?
|
| Prevalence | 1 | 2018 | 955 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 1212 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 293 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 534 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 325 | 0.100 |
Why?
|
| Adult | 2 | 2017 | 9263 | 0.090 |
Why?
|
| Risk Factors | 1 | 2018 | 3937 | 0.080 |
Why?
|
| Aged | 2 | 2018 | 10259 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2014 | 3409 | 0.060 |
Why?
|
| Blood-Brain Barrier | 1 | 2018 | 52 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2018 | 47 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2016 | 16 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2016 | 63 | 0.030 |
Why?
|
| Acute Coronary Syndrome | 1 | 2018 | 167 | 0.030 |
Why?
|
| Animals | 1 | 2016 | 8197 | 0.010 |
Why?
|